These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 7162468

  • 21. DNA replication in methotrexate-treated human lymphoblasts.
    Fridland A, Brent TP.
    Eur J Biochem; 1975 Sep 15; 57(2):379-85. PubMed ID: 1175648
    [Abstract] [Full Text] [Related]

  • 22. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
    Vilpo JA, Vilpo LM.
    Cancer Res; 1988 Jun 01; 48(11):3117-22. PubMed ID: 3163271
    [Abstract] [Full Text] [Related]

  • 23. Effect of 1-beta-D-arabinofuranosylcytosine triphosphate on DNA synthesis in isolated HeLa cell nuclei.
    Wist E, Krokan H, Prydz H.
    Biochemistry; 1976 Aug 10; 15(16):3647-52. PubMed ID: 952882
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of DNA synthesis by 1-beta-D-arabinofuranosylcytosine.
    Bremerskov V.
    Biomedicine; 1975 May 10; 22(3):217-22. PubMed ID: 1174630
    [Abstract] [Full Text] [Related]

  • 25. Effects of DNA replication inhibitors on UV excision repair in synchronised human cells.
    Downes CS, Collins AR.
    Nucleic Acids Res; 1982 Sep 11; 10(17):5357-68. PubMed ID: 7145704
    [Abstract] [Full Text] [Related]

  • 26. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
    Verhoef V, Fridland A.
    Cancer Res; 1985 Aug 11; 45(8):3646-50. PubMed ID: 2410098
    [Abstract] [Full Text] [Related]

  • 27. Chromatin assembled in the presence of cytosine arabinoside has a short nucleosome repeat.
    Leffak IM.
    Nucleic Acids Res; 1983 Aug 25; 11(16):5451-66. PubMed ID: 6889133
    [Abstract] [Full Text] [Related]

  • 28. Synthesis of 4'-thio-beta-D-arabinofuranosylcytosine (4'-thio-ara-C) and comparison of its anticancer activity with that of ara-C.
    Tiwari KN, Shortnacy-Fowler AT, Cappellacci L, Parker WB, Waud WR, Montgomery JA, Secrist JA.
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug 25; 19(1-2):329-40. PubMed ID: 10772718
    [Abstract] [Full Text] [Related]

  • 29. 1-beta-D-arabinofuranosylcytosine is cytotoxic in quiescent normal lymphocytes undergoing DNA excision repair.
    Yamauchi T, Kawai Y, Ueda T.
    Jpn J Cancer Res; 2002 Dec 25; 93(12):1334-41. PubMed ID: 12495473
    [Abstract] [Full Text] [Related]

  • 30. Potentiation of chlorambucil toxicity in B-CLL lymphocytes using the DNA synthesis inhibitors aphidicolin and 1-beta-D-arabinofuranosylcytosine.
    Bramson J, Panasci L.
    Biochem Pharmacol; 1995 Jun 29; 50(1):131-5. PubMed ID: 7605339
    [Abstract] [Full Text] [Related]

  • 31. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
    Pallavicini MG, Gray JW, Folstad LJ.
    Cancer Res; 1982 Aug 29; 42(8):3125-31. PubMed ID: 7093956
    [Abstract] [Full Text] [Related]

  • 32. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA.
    Cancer Res; 1992 Nov 15; 52(22):6270-8. PubMed ID: 1423273
    [Abstract] [Full Text] [Related]

  • 33. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D, Herrick D, Crumpacker C, Schnipper L.
    Cancer Res; 1984 Jan 15; 44(1):69-73. PubMed ID: 6317173
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis.
    Nandy P, Lien EJ, Avramis VI.
    Anticancer Res; 1999 Jan 15; 19(3A):1625-33. PubMed ID: 10470093
    [Abstract] [Full Text] [Related]

  • 35. An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents.
    Abdel-Aziz W, Hickey RJ, Malkas LH.
    Biochem Pharmacol; 2004 Jul 01; 68(1):11-21. PubMed ID: 15183113
    [Abstract] [Full Text] [Related]

  • 36. Differential inhibition of the human cell DNA replication complex-associated DNA polymerases by the antimetabolite 1-beta-D-arabinofuranosylcytosine triphosphate (ara-CTP).
    Han S, Hickey RJ, Tom TD, Wills PW, Syväoja JE, Malkas LH.
    Biochem Pharmacol; 2000 Aug 01; 60(3):403-11. PubMed ID: 10856436
    [Abstract] [Full Text] [Related]

  • 37. Effect of cytosine arabinoside on replicon initiation in human lymphoblasts.
    Fridland A.
    Biochem Biophys Res Commun; 1977 Jan 10; 74(1):72-8. PubMed ID: 836288
    [No Abstract] [Full Text] [Related]

  • 38. Potentiation of 1-beta-D-arabinofuranosylcytosine cytotoxicity to HL-60 cells by 1,25-dihydroxyvitamin D3 correlates with reduced rate of maturation of DNA replication intermediates.
    Studzinski GP, Reddy KB, Hill HZ, Bhandal AK.
    Cancer Res; 1991 Jul 01; 51(13):3451-5. PubMed ID: 2054784
    [Abstract] [Full Text] [Related]

  • 39. Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937.
    Horber DH, Schott H, Schwendener RA.
    Cancer Chemother Pharmacol; 1995 Jul 01; 36(6):483-92. PubMed ID: 7554040
    [Abstract] [Full Text] [Related]

  • 40. Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro.
    Streifel JA, Howell SB.
    Proc Natl Acad Sci U S A; 1981 Aug 01; 78(8):5132-6. PubMed ID: 6975478
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.